A Multi-Center, Open-Label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren’s Syndrome Patients
Trials（2023）
关键词
Primary Sjogren’s syndrome,JAK/STAT,Baricitinib,Hydroxychloroquine,ESSDAI
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要